UNLABELLED: Previous studies have not examined patterns of pain treatment use among patients seeking office-based buprenorphine-naloxone treatment (BNT) for opioid dependence. OBJECTIVES: To examine, among individuals with pain seeking BNT for opioid dependence, the use of pain treatment modalities, perceived efficacy of prior pain treatment, and interest in pursuing pain treatment while in BNT. METHODS: A total of 244 patients seeking office-based BNT for opioid dependence completed measures of demographics, pain status (ie, "chronic pain (CP)" [pain lasting at least 3 months] vs "some pain (SP)" [pain in the past week not meeting the duration criteria for chronic pain]), pain treatment use, perceived efficacy of prior pain treatment, and interest in receiving pain treatment while in BNT. RESULTS: In comparison with the SP group (N = 87), the CP group (N = 88) was more likely to report past-week medical use of opioid medication (adjusted odds ratio [AOR] = 3.2; 95% CI, 1.2-8.4), lifetime medical use of nonopioid prescribed medication (AOR = 2.2; 95% CI, 1.1-4.7), and lifetime use of prayer (AOR = 2.8; 95% CI, 1.2-6.5) and was less likely to report lifetime use of yoga (AOR = 0.2; 95% CI, 0.1-0.7) to treat pain. Although the 2 pain groups did not differ on levels of perceived efficacy of prior lifetime pain treatments, in comparison with the SP group, the CP group was more likely to report interest in receiving pain treatment while in BNT (P < 0.001). CONCLUSIONS: Individuals with pain seeking BNT for opioid dependence report a wide range of conventional, complementary, and alternative pain-related treatments and are interested (especially those with CP) in receiving pain management services along with BNT.
UNLABELLED: Previous studies have not examined patterns of pain treatment use among patients seeking office-based buprenorphine-naloxone treatment (BNT) for opioid dependence. OBJECTIVES: To examine, among individuals with pain seeking BNT for opioid dependence, the use of pain treatment modalities, perceived efficacy of prior pain treatment, and interest in pursuing pain treatment while in BNT. METHODS: A total of 244 patients seeking office-based BNT for opioid dependence completed measures of demographics, pain status (ie, "chronic pain (CP)" [pain lasting at least 3 months] vs "some pain (SP)" [pain in the past week not meeting the duration criteria for chronic pain]), pain treatment use, perceived efficacy of prior pain treatment, and interest in receiving pain treatment while in BNT. RESULTS: In comparison with the SP group (N = 87), the CP group (N = 88) was more likely to report past-week medical use of opioid medication (adjusted odds ratio [AOR] = 3.2; 95% CI, 1.2-8.4), lifetime medical use of nonopioid prescribed medication (AOR = 2.2; 95% CI, 1.1-4.7), and lifetime use of prayer (AOR = 2.8; 95% CI, 1.2-6.5) and was less likely to report lifetime use of yoga (AOR = 0.2; 95% CI, 0.1-0.7) to treat pain. Although the 2 pain groups did not differ on levels of perceived efficacy of prior lifetime pain treatments, in comparison with the SP group, the CP group was more likely to report interest in receiving pain treatment while in BNT (P < 0.001). CONCLUSIONS: Individuals with pain seeking BNT for opioid dependence report a wide range of conventional, complementary, and alternative pain-related treatments and are interested (especially those with CP) in receiving pain management services along with BNT.
Authors: Declan T Barry; Kevin S Irwin; Emlyn S Jones; William C Becker; Jeanette M Tetrault; Lynn E Sullivan; Helena Hansen; Patrick G O'Connor; Richard S Schottenfeld; David A Fiellin Journal: J Pain Date: 2010-06-02 Impact factor: 5.820
Authors: Declan T Barry; Jonathan D Savant; Mark Beitel; Christopher J Cutter; Brent A Moore; Richard S Schottenfeld; David A Fiellin Journal: Am J Addict Date: 2013 May-Jun
Authors: Robert Sheu; David Lussier; Andrew Rosenblum; Chunki Fong; Jason Portenoy; Herman Joseph; Russell K Portenoy Journal: Pain Med Date: 2008-03-11 Impact factor: 3.750
Authors: Declan T Barry; Mark Beitel; Christopher J Cutter; Brian Garnet; Dipa Joshi; Richard S Schottenfeld; Bruce J Rounsaville Journal: Am J Addict Date: 2009 Sep-Oct
Authors: Andrew Rosenblum; Herman Joseph; Chunki Fong; Steven Kipnis; Charles Cleland; Russell K Portenoy Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: Kelly E Dunn; Patrick H Finan; D Andrew Tompkins; Michael Fingerhood; Eric C Strain Journal: Drug Alcohol Depend Date: 2015-10-19 Impact factor: 4.492
Authors: Sandra D Comer; Verena E Metz; Ziva D Cooper; William J Kowalczyk; Jermaine D Jones; Maria A Sullivan; Jeanne M Manubay; Suzanne K Vosburg; Mary E Smith; Deena Peyser; Phillip A Saccone Journal: Behav Pharmacol Date: 2013-09 Impact factor: 2.293
Authors: Lindsay M Oberleitner; Mark Beitel; Richard S Schottenfeld; Robert D Kerns; Christopher Doucette; Renee Napoleone; Christopher Liong; Declan T Barry Journal: J Addict Med Date: 2016 Jan-Feb Impact factor: 3.702
Authors: Michael D Stein; Debra S Herman; Genie L Bailey; John Straus; Bradley J Anderson; Lisa A Uebelacker; Risa B Weisberg Journal: J Gen Intern Med Date: 2015-02-13 Impact factor: 5.128
Authors: Frank D Buono; Lauretta E Grau; Matthew E Sprong; Kenneth L Morford; Kimberly J Johnson; David H Gutmann Journal: J Pain Res Date: 2019-08-22 Impact factor: 3.133